Prime Medicine, Common Etf Analysis

PRME Etf  USD 3.30  0.04  1.20%   
Prime Medicine, Common is undervalued with Real Value of 5.62 and Target Price of 22.17. The main objective of Prime Medicine, etf analysis is to determine its intrinsic value, which is an estimate of what Prime Medicine, Common is worth, separate from its market price. There are two main types of Prime Etf analysis: fundamental analysis and technical analysis.
The Prime Medicine, etf is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Prime Medicine,'s ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prime Medicine, Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in population.

Prime Etf Analysis Notes

The fund maintains 99.55% of assets in stocks. Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange. To find out more about Prime Medicine, Common contact Keith MD at 617 564 0013 or learn more at https://primemedicine.com.

Prime Medicine, Common Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more etfs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Prime Medicine,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Prime Medicine, Common or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Prime Medicine, generated a negative expected return over the last 90 days
Prime Medicine, has high historical volatility and very poor performance
Net Loss for the year was (198.13 M) with loss before overhead, payroll, taxes, and interest of (86.72 M).
Prime Medicine, Common currently holds about 146.66 M in cash with (165.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 62.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Is Prime Medicine In A Good Position To Deliver On Growth Plans
The fund maintains 99.55% of its assets in stocks

Prime Medicine, Common Upcoming and Recent Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Prime Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
1.4 M
Millennium Management Llc2024-06-30
1.3 M
State Street Corp2024-06-30
1.1 M
Baker Bros Advisors Lp2024-09-30
M
Deerfield Management Co2024-09-30
897 K
Farallon Capital Management, L.l.c.2024-09-30
750 K
Greenwich Wealth Management Llc2024-09-30
733 K
Ecor1 Capital, Llc2024-09-30
700 K
Avidity Partners Management Lp2024-09-30
694 K
Alphabet Inc2024-09-30
15.1 M
Ark Investment Management Llc2024-09-30
5.7 M
Note, although Prime Medicine,'s institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prime Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 432.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prime Medicine,'s market, we take the total number of its shares issued and multiply it by Prime Medicine,'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Prime Medicine, Common has return on total asset (ROA) of (0.4651) % which means that it has lost $0.4651 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1435) %, meaning that it created substantial loss on money invested by shareholders. Prime Medicine,'s management efficiency ratios could be used to measure how well Prime Medicine, manages its routine affairs as well as how well it operates its assets and liabilities.
Prime Medicine, Common has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Operating Margin
(259.48)
Beta
2.093
Return On Assets
(0.47)
Return On Equity
(1.14)

Top Prime Medicine, Common Etf Constituents

Technical Drivers

As of the 28th of November, Prime Medicine, holds the Risk Adjusted Performance of (0.03), coefficient of variation of (1,865), and Variance of 26.27. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prime Medicine,, as well as the relationship between them. Please check Prime Medicine, Common standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Prime Medicine, Common is priced some-what accurately, providing market reflects its current price of 3.3 per share.

Prime Medicine, Common Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Prime Medicine, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Prime Medicine, Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Prime Medicine, Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prime Medicine, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prime Medicine,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prime Medicine, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Cahill Thomas over three weeks ago
Acquisition by Cahill Thomas of 45000 shares of Prime Medicine, at 7.68 subject to Rule 16b-3
 
Meredith Goldwasser over a month ago
Acquisition by Meredith Goldwasser of 90498 shares of Prime Medicine, at 8.49 subject to Rule 16b-3
 
Keith Gottesdiener over a month ago
Disposition of 226925 shares by Keith Gottesdiener of Prime Medicine, subject to Rule 16b-3
 
Gv 2023 Gp, L.l.c. over two months ago
Discretionary transaction by Gv 2023 Gp, L.l.c. of tradable shares of Prime Medicine, subject to Rule 16b-3
 
Gv 2019 Gp, L.l.c. over three months ago
Disposition of 28100 shares by Gv 2019 Gp, L.l.c. of Prime Medicine subject to Rule 16b-3
 
Marrazzo Jeffrey D over three months ago
Acquisition by Marrazzo Jeffrey D of 45000 shares of Prime Medicine at 7.68 subject to Rule 16b-3
 
Foster-cheek Kaye I over three months ago
Acquisition by Foster-cheek Kaye I of 45000 shares of Prime Medicine at 7.68 subject to Rule 16b-3
 
Keith Gottesdiener over three months ago
Acquisition by Keith Gottesdiener of 250000 shares of Prime Medicine subject to Rule 16b-3
 
Gv 2019 Gp, L.l.c. over six months ago
Disposition of 12602 shares by Gv 2019 Gp, L.l.c. of Prime Medicine subject to Rule 16b-3
 
Gv 2019 Gp Llc over six months ago
Sale by Gv 2019 Gp Llc of 28960 shares of Prime Medicine
 
Marrazzo Jeffrey D over six months ago
Acquisition by Marrazzo Jeffrey D of 250000 shares of Prime Medicine at 8.63 subject to Rule 16b-3
 
Gv 2019 Gp Llc over six months ago
Prime Medicine exotic insider transaction detected

Prime Medicine, Outstanding Bonds

Prime Medicine, issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Prime Medicine, Common uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Prime bonds can be classified according to their maturity, which is the date when Prime Medicine, Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Prime Medicine, Predictive Daily Indicators

Prime Medicine, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Prime Medicine, etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Prime Medicine, Forecast Models

Prime Medicine,'s time-series forecasting models are one of many Prime Medicine,'s etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prime Medicine,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Prime Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how Prime Medicine, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prime shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Prime Medicine,. By using and applying Prime Etf analysis, traders can create a robust methodology for identifying Prime entry and exit points for their positions.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.

Current Prime Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Prime analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Prime analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
22.17Strong Buy12Odds
Prime Medicine, Common current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Prime analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Prime stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Prime Medicine, Common, talking to its executives and customers, or listening to Prime conference calls.
Prime Analyst Advice Details

Prime Etf Analysis Indicators

Prime Medicine, Common etf analysis indicators help investors evaluate how Prime Medicine, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Prime Medicine, shares will generate the highest return on investment. By understating and applying Prime Medicine, etf analysis, traders can identify Prime Medicine, position entry and exit signals to maximize returns.
Begin Period Cash Flow201.1 M
Total Stockholder Equity133.1 M
Capital Lease Obligations13.6 M
Property Plant And Equipment Net36.6 M
Cash And Short Term Investments121.7 M
Net Invested Capital133.1 M
Cash41.6 M
200 Day M A5.4173
50 Day M A3.7664
Total Current Liabilities56.4 M
Investments-36.3 M
Stock Based Compensation13.9 M
Common Stock Shares Outstanding91 M
Tax Provision-465 K
Free Cash Flow-174.1 M
Operating Income-191.3 M
Other Current Assets21.3 M
Accounts Payable19.5 M
Net Debt-27.9 M
Depreciation4.7 M
Other Operating Expenses191.3 M
Non Current Assets Total50.9 M
Liabilities And Stockholders Equity193.9 M
Non Currrent Assets Other14.3 M

Other Information on Investing in Prime Etf

Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.